Lexaria Bioscience Corp. (LEXX) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Lexaria Bioscience Corp. (LEXX) closed at USD 2.99 on 2026-10-15, a change of -79.2 % over the past year, with a market capitalization of USD 6.02M.

Lexaria Bioscience Corp. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Lexaria Bioscience Corp. key figures

Previous close

USD 2.99 (2026-10-15)

1-year change

-79.2 %

Market cap

USD 6.02M

Enterprise value

USD 801,779

P/E ratio (trailing)

-0.56

P/E ratio (forward)

-7.33

EPS (trailing)

-5.10

EPS (forward)

-0.39

PEG ratio

n/a

Price to book

1.00

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

2.68

Employees

7

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. The company's DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, epilepsy, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, and oral products; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Lexaria Bioscience Corp. and compare it with other stocks.